2) Early-stage breast cancer 早期乳腺癌 1. Herceptin plus adjuvant chemotherahy for the prognosis of patients with human epithelial growth factor receptor 2 positive early-stage breast cancer: a Meta-analysis; 赫赛汀联合辅助化疗对人类表皮生长因子受体2阳性早期乳腺癌患者预后影响的Meta分析 2. ...
Early stage breast cancerLate toxicitySecond cancer mortalitySurveillance, Epidemiology, and End Results (SEERINTRODUCTION/: With improved BC screening and treatment, the risk for long-term toxicities of treatments must be considered, especially in good prognosis patients. In this study we examined the...
The expression of IL1β in triple negative breast cancer (TNBC) has been associated with macrophage-induced immune suppression and cancer progression. Here the authors report that ETS1-driven caspase-1 expression is a feature of TNBC and is required for IL1β-mediated macrophage recruitment and ...
Breast Cancer Recurrence, Early Stage 1, 2 Breast Cancer Test, Prognostic Test For Breast Cancer In India, Tumour Test, Screening Test, Oncotype dx Test in India, CanAssistBreast, Oncostem, India
Purpose: Stage IA (T1N0M0) non-small cell lung cancer (NSCLC) includes all lesions up to 3 cm in diameter. With the use of advanced imaging techniques, sma... A Gajra,N Newman,GP Gamble,... - 《Lung Cancer》 被引量: 266发表: 2003年 Factors influencing survival and prognosis in ...
Learn about the breast cancer experience, from symptoms and tests to treatments, recovery, and prevention. Pictures show breast structure and tumors.
Adaptive phase II randomized trial of nivolumab after induction treatment in triple negative breast cancer (TONIC trial): final response data stage I and first translational data. J Clin Oncol. 2018;36(15 suppl):1012.Google ScholarCrossref 35. Loibl S, Untch M, Burchardi N, et al. ...
Findings In this phase 1 nonrandomized clinical trial of 66 patients with advanced-stage ERBB2-positive breast cancer, a majority grade 1/2 adverse events were generated for all doses. Patients in arms 2 (100 μg) and 3 (500 μg) had higher magnitude ICD T-cell levels than those in ...
133. The biological and prognostic value of tumour size (T1a, T1b and T1c) in breast cancer stage IThe aim of the investigation is to study the dynamics of approaches in surgery, adjuvant radiotherapy and systemic therapy for breast cancer stage I over the past 27 years. Materials and ...
Breast-conserving surgery followed by radiotherapy is part of standard treatment for early-stage breast cancer. Hypoxia is common in cancer and may affect the benefit of radiotherapy. Cells adapt to hypoxic stress largely via the transcriptional activity of hypoxia-inducible factor (HIF)-1α. Here,...